BioHarvest Sciences Inc., listed on NASDAQ under the ticker BHST, has announced the effectiveness of a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission. This registration allows the company to offer and sell up to $100 million of its common shares, warrants, and units, subject to market conditions and the company's capital needs. The terms and pricing of any offerings will be detailed in a prospectus supplement at the time of the offering. The company emphasizes that this registration does not obligate them to sell any securities, and any offerings will be at their discretion based on market conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001139020-25-000300), on September 09, 2025, and is solely responsible for the information contained therein.
Comments